Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Voya Financial
VOYA
|
+$81.9M |
| 2 |
SPR
Spirit AeroSystems
SPR
|
+$68.8M |
| 3 |
Goldman Sachs
GS
|
+$64.1M |
| 4 |
AbbVie
ABBV
|
+$58.2M |
| 5 |
Citigroup
C
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$85.8M |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$60.3M |
| 3 |
Morgan Stanley
MS
|
+$52.6M |
| 4 |
Expedia Group
EXPE
|
+$47.8M |
| 5 |
Centene
CNC
|
+$41.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.2% |
| 2 | Financials | 14.02% |
| 3 | Technology | 13.59% |
| 4 | Industrials | 10.74% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADPT
2526
DELISTED
Adeptus Health Inc
ADPT
| $770K | ﹤0.01% |
8,100
| – | – |
|
|
WCIC
2527
DELISTED
WCI Communities, Inc.
WCIC
| $767K | ﹤0.01% |
31,415
+1,066
| +4% | +$25.4K |
|
2528
LGI Homes
LGIH
$1.36B
| $759K | ﹤0.01% |
38,361
-12,873
| -25% | -$231K |
|
|
BMCH
2529
DELISTED
BMC Stock Holdings, Inc
BMCH
| $756K | ﹤0.01% |
38,645
+1,312
| +4% | +$24.6K |
|
2530
Amphastar Pharmaceuticals
AMPH
$869M
| $755K | ﹤0.01% |
42,926
+30,226
| +238% | +$471K |
|
|
TPLM
2531
DELISTED
Triangle Petroleum Corporation
TPLM
| $753K | ﹤0.01% |
149,845
-71,506
| -32% | -$384K |
|
|
AAC
2532
DELISTED
AAC Holdings
AAC
| $752K | ﹤0.01% |
17,263
+4,710
| +38% | +$173K |
|
|
CBR
2533
DELISTED
CIBER Inc.
CBR
| $751K | ﹤0.01% |
217,448
+5,658
| +3% | +$20.6K |
|
|
BBBY
2534
Bed Bath & Beyond
BBBY
$413M
| $749K | ﹤0.01% |
44,214
+1,855
| +4% | +$31.5K |
|
2535
Extreme Networks
EXTR
$3.12B
| $744K | ﹤0.01% |
276,243
+8,938
| +3% | +$24.1K |
|
|
PSTB
2536
DELISTED
Park Sterling Corp.
PSTB
| $744K | ﹤0.01% |
103,298
+11,960
| +13% | +$82.9K |
|
|
ECYT
2537
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $743K | ﹤0.01% |
143,142
+4,023
| +3% | +$24.1K |
|
|
WLB
2538
DELISTED
Westmoreland Coal Company
WLB
| $741K | ﹤0.01% |
35,652
+4,552
| +15% | +$121K |
|
|
VIVS
2539
VivoSim Labs
VIVS
$1.25M
| $739K | ﹤0.01% |
816
+121
| +17% | +$135K |
|
|
REXX
2540
DELISTED
Rex Energy Corporation
REXX
| $739K | ﹤0.01% |
13,207
+410
| +3% | +$20.4K |
|
|
LIOX
2541
DELISTED
Lionbridge Technologies
LIOX
| $737K | ﹤0.01% |
119,400
| – | – |
|
2542
Ternium
TX
$10.8B
| $734K | ﹤0.01% |
42,386
+15,242
| +56% | +$300K |
|
|
SQBK
2543
DELISTED
SQUARE 1 FINANCIAL INC COM
SQBK
| $729K | ﹤0.01% |
26,635
+11,638
| +78% | +$311K |
|
2544
NN Inc
NNBR
$306M
| $728K | ﹤0.01% |
28,500
| – | – |
|
|
USCR
2545
DELISTED
U S Concrete, Inc.
USCR
| $728K | ﹤0.01% |
19,200
| – | – |
|
|
IBTX
2546
DELISTED
Independent Bank Group, Inc.
IBTX
| $726K | ﹤0.01% |
16,923
+246
| +1% | +$10K |
|
|
CMLS
2547
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $722K | ﹤0.01% |
44,430
+1,312
| +3% | +$24.5K |
|
|
SRNE
2548
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $722K | ﹤0.01% |
+40,955
| New | +$526K |
|
2549
Calix
CALX
$2.46B
| $721K | ﹤0.01% |
94,706
+2,788
| +3% | +$22.7K |
|
|
OME
2550
DELISTED
Omega Protein
OME
| $719K | ﹤0.01% |
52,231
-163,979
| -76% | -$2.18M |
|
Similar funds
Charles Schwab's Q2 2015 Portfolio in Review
As of Q2 2015, Charles Schwab held 3,232 positions worth $72.4B, up 1.8% from $71.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab's Q2 2015 filing shows 150 new, 2,258 increased, 427 reduced and 137 closed positions. Its largest new stake was Citizens Financial Group: 394,487 shares worth $10.8M. The largest sale was Merck, an estimated $85.8M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
- Charles Schwab's largest Q2 2015 buy was Citizens Financial Group: 394,487 shares worth $10.8M.
- Charles Schwab added most to Voya Financial in Q2 2015, an estimated $81.9M increase.
- Charles Schwab's biggest Q2 2015 reduction was Merck, cutting an estimated $85.8M.
- Charles Schwab fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $60.3M.
- Charles Schwab's ten largest holdings make up 14% of its $72.4B portfolio in Q2 2015.
- Charles Schwab opened 150 new positions and closed 137 in Q2 2015.
- Charles Schwab's portfolio value rose 1.8% quarter-over-quarter to $72.4B.
Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.